Where does ModernaTX, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ModernaTX, Inc. ranks #1,797 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ModernaTX, Inc. hold?

ModernaTX, Inc. holds 227 US utility patents granted between 2016 and 2025, spanning 24 technology areas.

What is ModernaTX, Inc.'s Innovation Score?

ModernaTX, Inc. has an Innovation Score of 54.6 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does ModernaTX, Inc. focus on?

ModernaTX, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 200 patents, ranking #89 of 7,163 assignees active in that subclass. Grants appear in 24 CPC subclasses total.

Is ModernaTX, Inc.'s patent grant rate increasing or decreasing?

ModernaTX, Inc.'s recent grant velocity is +70% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for ModernaTX, Inc.'s patents?

ModernaTX, Inc.'s patents average 20.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ModernaTX, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ModernaTX, Inc.

USPTO PatentsView assignee record - 227 granted patents across 24 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Modernatx ranks #1,797 of 49,997 tracked US assignees by granted-patent volume, with 227 patents across 24 technology areas.

#1,797
of 49,997 US assignees by volume: Top 8%
by Innovation Score (54.6/100): 20.7
avg claims per patent: +70%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1797 · US Corporation #1,797 · 227 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 227 grants
TOP-DECILE #1,797/49,997
PHOTO-FINISH Flooring Industies…
CPC-FOCUS A61K · 24 areas
INNOV-PAR 54.6/100
CLAIMS-DENSE 20.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +70% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Flooring Industies Limited, Sarl (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Modernatx’s 54.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 18.8 pts (34%) Velocity 6.1 pts (11%) Breadth 17.3 pts (32%) Claim depth 12.4 pts (23%)

Qualcomm Incorporated · highest

85
Furukawa Automotive… · near

55
Camso · near

55
ModernaTX · this assignee

55
PFU · near

55
Universitat Stuttgart · near

55
3D Lighting… · lowest

7

What this shows Modernatx's Innovation Score is 54.6/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Modernatx?

Each dot is one of Modernatx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Modernatx’s own 20.7 claims/patent is ABOVE the 15.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Modernatx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Modernatx's grants concentrate

ModernaTX, Inc. is a focused PatentsView assignee: 24 CPC subclasses with 88.1% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (37 grants) versus a trough of 2 in 2016. By volume, Modernatx sits between Flooring Industies Limited, Sarl and Western Digital (FREMONT), LLC.

Modernatx's three-year grant acceleration

From 2019–2021 to 2022–2024, ModernaTX, Inc. moved from 84 to 77 grants (0.92x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,418. See the growth leaderboard.

Flooring Industie…

227
Grammer

227
General Motors

227
Lattice Semicondu…

227
Ningbo Sunny Opot…

227
Nasdaq

227
Sharp Display Tec…

227
Western Digital (…

227
Modernatx ◀

227

What this shows ModernaTX holds 227 patents at rank #1,797, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ModernaTX

By rank, the assignees closest to #1,797 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in ModernaTX's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ModernaTX, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), ModernaTX ranks #89 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (55 here).

PFU Limited 55 Universitat Stuttgart 55 Camso Inc. 55 Furukawa Automotive Systems Inc. 55

Similar claim depth

Nearest assignees by average claims per patent (20.7 here).

Atomera Incorporated 20.7 avg Regeneron Pharmaceuticals, Inc. 20.7 avg Ampere Computing LLC 20.7 avg Imagine Communications Corp. 20.7 avg

Modernatx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 8% higher than 92% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

ModernaTX, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	0.9%
2017	13	5.7%
2018	21	9.3%
2019	37	16.3%
2020	25	11.0%
2021	22	9.7%
2022	22	9.7%
2023	26	11.5%
2024	29	12.8%
2025partial year	30	13.2%

Which technologies does ModernaTX, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 200

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 174

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 145

C07K - Peptides 119

C12Y - Enzymes 46

Y02A - Technologies FOR Adaptation TO Climate Change 44

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 33

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 23

C07D - Heterocyclic Compounds 21

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 21

C07C - Acyclic OR Carbocyclic Compounds 17

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 14

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 14

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 8

G06F - Electric Digital Data Processing 6

Top 15 of 24 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ModernaTX, Inc.'s patent record in context - here's where to go next.

ModernaTX, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 88.1% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #1,797 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ModernaTX, Inc. against Flooring Industies Limited, Sarl, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 54.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.